(19)
(11) EP 4 680 198 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24713994.2

(22) Date of filing: 15.03.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
 A61K 47/14(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0019; A61K 47/14
(86) International application number:
PCT/FI2024/050119
(87) International publication number:
WO 2024/189275 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.03.2023 FI 20235300

(71) Applicant: Sartar Therapeutics Oy
00290 Helsinki (FI)

(72) Inventors:
  • VAN DEN HEUVEL, Dennie
    00290 Helsinki (FI)
  • IVANITSKIY, Katja
    00290 Helsinki (FI)
  • MAKSIMOW, Mikael
    00290 Helsinki (FI)

(74) Representative: Laine IP Oy 
Porkkalankatu 24
00180 Helsinki
00180 Helsinki (FI)

   


(54) A PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS INJECTION OF ANAGRELIDE